## KHC: The Kraft Heinz Company - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.00 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($23.31)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Orion Porfolio Solutions LLC Sells 51,609 Shares of Kraft Heinz Company $KHC**
- Source: MarketBeat | 20251221T103804 | Somewhat-Bearish | Relevance: 100%
- Orion Portfolio Solutions LLC has significantly reduced its stake in Kraft Heinz Company (NASDAQ:KHC) by selling 51,609 shares, leaving them with 65,082 shares valued at $1.68 million. This comes as insider Miguel Patricio also sold 125,000 shares, reducing his position by 15.4%. Despite a quarterly dividend declaration, analysts maintain a "Reduce" rating with a target price of $26.63 for KHC.

**2. Adams Asset Advisors LLC Sells 85,829 Shares of Kraft Heinz Company $KHC**
- Source: MarketBeat | 20251220T080802 | Somewhat-Bearish | Relevance: 100%
- Adams Asset Advisors LLC significantly reduced its stake in Kraft Heinz Company, selling 85,829 shares in Q3, now holding 212,024 shares valued at $5.52 million. This move coincides with an insider sale by Miguel Patricio and a consensus analyst rating of "Reduce" for Kraft Heinz, despite its declared quarterly dividend of $0.40 per share.

**3. Pantry Powerhouse: A Deep-Dive into General Mills (GIS) in the Age of GLP-1 and Pet Humanization**
- Source: FinancialContent | 20251222T150834 | Somewhat-Bullish | Relevance: 74%
- General Mills (GIS) is navigating a dynamic market influenced by health-conscious consumers adopting GLP-1 weight-loss drugs and the growing trend of pet humanization. The company's recent Q2 FY2026 earnings beat, driven by strategic portfolio reshaping, including the divestiture of its yogurt business and focus on pet nutrition via Blue Buffalo, demonstrates its adaptability. GIS is trading at a discount, offers a robust dividend yield, and is poised for continued growth through innovation in high-protein products and the fresh pet food market.

**4. Coty names P&G's Strobel as interim chief; Nabi to leave company**
- Source: Reuters | 20251222T080944 | Neutral | Relevance: 74%
- Coty has appointed Procter & Gamble veteran Markus Strobel as interim CEO and chairman, effective January 1, following Sue Nabi's departure after five years. This leadership change comes as Coty's shares have fallen significantly this year due to struggles in its mass-market business and intense competition. The company is also conducting a strategic review of its consumer beauty unit, which could lead to selling brands like CoverGirl and Rimmel.

**5. Coty Names P&G's Strobel As Interim Chief; Nabi To Leave Company**
- Source: ESM Magazine | 20251222T100944 | Somewhat-Bullish | Relevance: 73%
- Coty, the US cosmetics maker, has appointed Markus Strobel, a Procter & Gamble veteran, as its interim chief executive and executive chairman. This leadership change comes as Coty battles a significant share-price slide and challenges in its mass-market business, with former CEO Sue Nabi stepping down after five years. Strobel, who previously led P&G's global skin and personal care division, will assume his role on January 1st, tasked with accelerating growth and strengthening Coty's position in the beauty market.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Piper Sandler | $27 | $25 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Berkshire Hathaway, : 27.5% (0.0%)
- Vanguard Group Inc: 8.6% (-0.1%)
- Blackrock Inc.: 7.6% (-7.4%)
- State Street Corpora: 3.9% (-0.6%)
- Geode Capital Manage: 2.3% (+3.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.7% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 10.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.00 suggests fair value with growth premium. Analyst sentiment positive (1 raises, avg +8%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.6B |
| Beta | 0.07 |
| 52W Range | $23.70 - $33.35 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 9.6 |
| Current P/E | 9.5 |
| YoY Growth | -0.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.1% to -2.8% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.90x), long-term trend not supportive. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.84% (CS: 20) | Weak |
| RSI_14 | 38.3 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.971x | Below |
| vs SMA200 | 0.896x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $24.15
- **Stop Loss:** $23.31 (3.5% risk)
- **Target:** $25.83 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 714
- **Position Value:** $17,243.10
- **Portfolio %:** 17.24%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-11 (Est: $0.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.58 | $0.61 | +5.8% |
| 2025Q2 | $0.64 | $0.69 | +8.4% |
| 2025Q1 | $0.60 | $0.62 | +3.1% |
| 2024Q4 | $0.78 | $0.84 | +7.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*